{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T23:12:53Z","timestamp":1773184373863,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011795","name":"Beijing Polytechnic University","doi-asserted-by":"publisher","award":["2024X007-KXZ"],"award-info":[{"award-number":["2024X007-KXZ"]}],"id":[{"id":"10.13039\/501100011795","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Natural Science Foundation","award":["7254488"],"award-info":[{"award-number":["7254488"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02889-2","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T10:20:44Z","timestamp":1756203644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Discovery of a novel broad-spectrum inhibitor against influenza virus A"],"prefix":"10.1186","volume":"22","author":[{"given":"Ran","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenting","family":"Fei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"2889_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112518","volume":"146","author":"A Abdi","year":"2022","unstructured":"Abdi A, AlOtaiby S, Badarin FA, Khraibi A, Hamdan H, Nader M. Interaction of SARS-CoV-2 with cardiomyocytes: insight into the underlying molecular mechanisms of cardiac injury and pharmacotherapy. Biomed Pharmacother. 2022;146: 112518.","journal-title":"Biomed Pharmacother"},{"key":"2889_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpc.2021.106663","volume":"277","author":"AA Ahmed","year":"2021","unstructured":"Ahmed AA, Abouzid M. Arbidol targeting influenza virus A hemagglutinin; a comparative study. Biophys Chem. 2021;277: 106663.","journal-title":"Biophys Chem"},{"key":"2889_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2023.108405","volume":"120","author":"S AlRawashdeh","year":"2023","unstructured":"AlRawashdeh S, Chandrasekaran S, Barakat KH. Structural analysis of hERG channel blockers and the implications for drug design. J Mol Graph Model. 2023;120: 108405.","journal-title":"J Mol Graph Model"},{"key":"2889_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.102944","volume":"299","author":"S Amatsu","year":"2023","unstructured":"Amatsu S, Matsumura T, Zuka M, Fujinaga Y. Molecular engineering of a minimal E-cadherin inhibitor protein derived from Clostridium botulinum hemagglutinin. J Biol Chem. 2023;299: 102944.","journal-title":"J Biol Chem"},{"key":"2889_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.str.2020.12.007","volume":"29","author":"T Asai","year":"2021","unstructured":"Asai T, Adachi N, Moriya T, Oki H, Maru T, Kawasaki M, Suzuki K, Chen S, Ishii R, Yonemori K, Igaki S, Yasuda S, Ogasawara S, Senda T, Murata T. Cryo-EM Structure of K+-Bound hERG channel complexed with the blocker astemizole. Structure. 2021;29:203-12.e4.","journal-title":"Structure"},{"key":"2889_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2022.107764","volume":"101","author":"T Boonma","year":"2022","unstructured":"Boonma T, Soikudrua N, Nutho B, Rungrotmongkol T, Nunthaboot N. Insights into binding molecular mechanism of hemagglutinin H3N2 of influenza virus complexed with arbidol and its derivative: a molecular dynamics simulation perspective. Comput Biol Chem. 2022;101: 107764.","journal-title":"Comput Biol Chem"},{"key":"2889_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.virol.2023.04.002","volume":"582","author":"A Bosco-Lauth","year":"2023","unstructured":"Bosco-Lauth A, Rodriguez A, Maison RM, Porter SM, Jeffrey Root J. H7N9 influenza A virus transmission in a multispecies barnyard model. Virology. 2023;582:100\u20135.","journal-title":"Virology"},{"key":"2889_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.antiviral.2013.05.005","volume":"99","author":"V Brancato","year":"2013","unstructured":"Brancato V, Peduto A, Wharton S, Martin S, More V, Di Mola A, Massa A, Perfetto B, Donnarumma G, Schiraldi C, Tufano MA, de Rosa M, Filosa R, Hay A. Design of inhibitors of influenza virus membrane fusion: synthesis, structure\u2013activity relationship and in vitro antiviral activity of a novel indole series. Antiviral Res. 2013;99:125\u201335.","journal-title":"Antiviral Res"},{"key":"2889_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105280","volume":"200","author":"SK Brown","year":"2022","unstructured":"Brown SK, Tseng Y-Y, Aziz A, Baz M, Barr IG. Characterization of influenza B viruses with reduced susceptibility to influenza neuraminidase inhibitors. Antiviral Res. 2022;200: 105280.","journal-title":"Antiviral Res"},{"key":"2889_CR10","unstructured":"Centers for Disease Control and Prevention. Effectiveness of Seasonal Flu Vaccines from the 2009\u20132025 Flu Seasons. 2024. https:\/\/www.cdc.gov\/flu-vaccines-work\/media\/files\/2025\/05\/Vaccine-Effectiveness-Chart-2025.xlsx."},{"key":"2889_CR11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ejmech.2014.03.069","volume":"78","author":"K Chauhan","year":"2014","unstructured":"Chauhan K, Singh P, Kumar V, Shukla PK, Siddiqi MI, Chauhan PMS. Investigation of Ugi-4CC derived 1H-tetrazol-5-yl-(aryl) methyl piperazinyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid: synthesis, biology and 3D-QSAR analysis. Eur J Med Chem. 2014;78:442\u201354.","journal-title":"Eur J Med Chem"},{"key":"2889_CR12","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.str.2022.04.003","volume":"30","author":"C-F Cheung","year":"2022","unstructured":"Cheung C-F, Gorman J, Andrews SF, Rawi R, Reveiz M, Shen C-H, Wang Y, Harris DR, Nazzari AF, Olia AS, Julie Raab I, Teng T, Verardi R, Wang S, Yang Y, Chuang G-Y, McDermott AB, Zhou T, Kwong PD. Structure of an influenza group 2-neutralizing antibody targeting the hemagglutinin stem supersite. Structure. 2022;30:993-1003.e6.","journal-title":"Structure"},{"key":"2889_CR13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3390\/v11050458","volume":"11","author":"R Du","year":"2019","unstructured":"Du R, Cui Q, Rong L. Competitive cooperation of hemagglutinin and neuraminidase during influenza A virus entry. Viruses. 2019;11:458.","journal-title":"Viruses"},{"key":"2889_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2021.105013","volume":"186","author":"R Du","year":"2021","unstructured":"Du R, Cheng H, Cui Q, Peet NP, Gaisina IN, Rong L. Identification of a novel inhibitor targeting influenza A virus group 2 hemagglutinins. Antiviral Res. 2021;186: 105013.","journal-title":"Antiviral Res"},{"key":"2889_CR15","doi-asserted-by":"publisher","first-page":"764a","DOI":"10.1016\/j.bpj.2013.11.4202","volume":"106","author":"S Friis","year":"2014","unstructured":"Friis S, Emma O, Kristina C, Richard K, Morten S. Current Clamp of Stem Cell Derived Cardiomyocytes on Qpatch. Biophysical Journal. 2014;106:764a.","journal-title":"Biophysical Journal."},{"key":"2889_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105281","volume":"200","author":"EA Govorkova","year":"2022","unstructured":"Govorkova EA, Takashita E, Daniels RS, Fujisaki S, Presser LD, Patel MC, Huang W, Lackenby A, Nguyen HT, Pereyaslov D, Rattigan A, Brown SK, Samaan M, Subbarao K, Wong S, Wang D, Webby RJ, Yen H-L, Zhang W, Meijer A, Gubareva LV. Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018\u20132020. Antivir Res. 2022;200: 105281.","journal-title":"Antivir Res"},{"key":"2889_CR17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00424-021-02518-1","volume":"473","author":"K Gu","year":"2021","unstructured":"Gu K, Qian D, Qin H, Chang Cui WC, Fernando HA, Wang D, Wang J, Cao K, Chen M. A novel mutation in KCNH2 yields loss-of-function of hERG potassium channel in long QT syndrome 2. Pfl\u00fcgers Arch Eur J Physiol. 2021;473:219\u201329.","journal-title":"Pfl\u00fcgers Arch Eur J Physiol"},{"key":"2889_CR18","doi-asserted-by":"publisher","DOI":"10.3201\/eid1502.081031","author":"SH Hauge","year":"2009","unstructured":"Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O. Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007\u201308. Emerg Infect Dis. 2009. https:\/\/doi.org\/10.3201\/eid1502.081031.","journal-title":"Emerg Infect Dis"},{"key":"2889_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/10406638.2021.1934045","author":"\u00d6zge\u00c7olako\u011flu Havare","year":"2022","unstructured":"Havare \u00d6zge\u00c7olako\u011flu. Quantitative structure analysis of some molecules in drugs used in the treatment of COVID-19 with topological indices. Polycycl Aromat Compd. 2022. https:\/\/doi.org\/10.1080\/10406638.2021.1934045.","journal-title":"Polycycl Aromat Compd"},{"key":"2889_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2023.101303","volume":"58","author":"MR Heindl","year":"2023","unstructured":"Heindl MR, B\u00f6ttcher-Friebertsh\u00e4user E. The role of influenza-A virus and coronavirus viral glycoprotein cleavage in host adaptation. Curr Opin Virol. 2023;58: 101303.","journal-title":"Curr Opin Virol"},{"key":"2889_CR21","doi-asserted-by":"publisher","first-page":"8808","DOI":"10.1128\/jvi.71.11.8808-8820.1997","volume":"71","author":"LR Hoffman","year":"1997","unstructured":"Hoffman LR, Kuntz ID, White JM. Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity. J Virol. 1997;71:8808\u201320.","journal-title":"J Virol"},{"key":"2889_CR22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1617020114","author":"RU Kadam","year":"2017","unstructured":"Kadam RU, Wilson IA. Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol. Proc Natl Acad Sci USA. 2017. https:\/\/doi.org\/10.1073\/pnas.1617020114.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2889_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2022.107229","volume":"118","author":"TI King","year":"2022","unstructured":"King TI, Indapurkar A, Tariq I, DePalma R, Mistry S, Alvarez-Baron C, Ismaiel OA, Wu Wendy, Chiu K, Patel V, Rouse R, Strauss DG, Matta MK. Determination of five positive control drugs in hERG external solution (buffer) by LC-MS\/MS to support in vitro hERG assay as recommended by ICH S7B. J Pharmacol Toxicol Methods. 2022;118: 107229.","journal-title":"J Pharmacol Toxicol Methods"},{"key":"2889_CR24","doi-asserted-by":"publisher","first-page":"163a","DOI":"10.1016\/j.bpj.2018.11.909","volume":"116","author":"SE Kochanek","year":"2019","unstructured":"Kochanek SE, Amaro RE. Markov state model of influenza hemagglutinin reveals structural basis for group 1 influenza inhibition by Arbidol. Biophys J. 2019;116:163a-a164.","journal-title":"Biophys J"},{"key":"2889_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.106087","volume":"128","author":"M Kokot","year":"2022","unstructured":"Kokot M, Weiss M, Zdovc I, Anderluh M, Hrast M, Minovski N. Diminishing hERG inhibitory activity of aminopiperidine-naphthyridine linked NBTI antibacterials by structural and physicochemical optimizations. Bioorg Chem. 2022;128: 106087.","journal-title":"Bioorg Chem"},{"key":"2889_CR26","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1016\/j.bpj.2015.10.044","volume":"109","author":"AL Lai","year":"2015","unstructured":"Lai AL, Freed JH. The interaction between influenza HA fusion peptide and transmembrane domain affects membrane structure. Biophys J. 2015;109:2523\u201336.","journal-title":"Biophys J"},{"key":"2889_CR27","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1016\/j.bpj.2019.07.029","volume":"117","author":"CL Lei","year":"2019","unstructured":"Lei CL, Clerx M, Gavaghan DJ, Polonchuk L, Mirams GR, Wang K. Rapid characterization of hERG channel kinetics i: using an automated high-throughput system. Biophys J. 2019;117:2438\u201354.","journal-title":"Biophys J"},{"key":"2889_CR28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.antiviral.2008.10.009","volume":"81","author":"IA Leneva","year":"2009","unstructured":"Leneva IA, Russell RJ, Boriskin YS, Hay AJ. Characteristics of arbidol-resistant mutants of influenza virus: Implications for the mechanism of anti-influenza action of arbidol. Antiviral Res. 2009;81:132\u201340.","journal-title":"Antiviral Res"},{"key":"2889_CR29","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1128\/jvi.71.5.4062-4070.1997","volume":"71","author":"G Luo","year":"1997","unstructured":"Luo G, Torri A, Harte WE, Danetz S, Cianci C, Tiley L, Day S, Mullaney D, Yu KL, Ouellet C, Dextraze P, Meanwell N, Colonno R, Krystal M. Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virus. J Virol. 1997;71:4062\u201370.","journal-title":"J Virol"},{"key":"2889_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2021.102479","volume":"40","author":"Y Ma","year":"2022","unstructured":"Ma Y, Wang Ye, Dong C, Gonzalez GX, Song Y, Zhu W, Kim J, Wei L, Wang B-Z. Influenza NP core and HA or M2e shell double-layered protein nanoparticles induce broad protection against divergent influenza A viruses. Nanomedicine: Nanotechnology Biology and Medicine. 2022;40: 102479.","journal-title":"Nanomedicine: Nanotechnology. Biology and Medicine"},{"key":"2889_CR31","doi-asserted-by":"crossref","unstructured":"Mar\u00edn-Garc\u00eda, Jos\u00e9. 'Chapter 17 - Post-Genomic Analysis of Dysrhythmias and Sudden Death.' in Jos\u00e9 Mar\u00edn-Garc\u00eda (ed.), Post-Genomic Cardiology (Second Edition) (Academic Press: Boston). 2014.","DOI":"10.1016\/B978-0-12-404599-6.00017-2"},{"key":"2889_CR32","doi-asserted-by":"publisher","first-page":"21548","DOI":"10.1074\/jbc.M117.816488","volume":"292","author":"BA McNally","year":"2017","unstructured":"McNally BA, Pendon ZD, Trudeau MC. hERG1a and hERG1b potassium channel subunits directly interact and preferentially form heteromeric channels. J Biol Chem. 2017;292:21548\u201357.","journal-title":"J Biol Chem"},{"key":"2889_CR33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.antiviral.2013.08.021","volume":"100","author":"ZH Nasser","year":"2013","unstructured":"Nasser ZH, Swaminathan K, M\u00fcller P, Downard KM. Inhibition of influenza hemagglutinin with the antiviral inhibitor arbidol using a proteomics based approach and mass spectrometry. Antiviral Res. 2013;100:399\u2013406.","journal-title":"Antiviral Res"},{"key":"2889_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53120-6","author":"T Negami","year":"2019","unstructured":"Negami T, Araki M, Okuno Y, Terada T. Calculation of absolute binding free energies between the hERG channel and structurally diverse drugs. Sci Rep. 2019. https:\/\/doi.org\/10.1038\/s41598-019-53120-6.","journal-title":"Sci Rep"},{"key":"2889_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173836","volume":"894","author":"AK Padhi","year":"2021","unstructured":"Padhi AK, Seal A, Khan JM, Ahamed M, Tripathi T. Unraveling the mechanism of arbidol binding and inhibition of SARS-CoV-2: insights from atomistic simulations. Eur J Pharmacol. 2021;894: 173836.","journal-title":"Eur J Pharmacol"},{"key":"2889_CR36","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1016\/j.vaccine.2011.05.062","volume":"29","author":"KS Park","year":"2011","unstructured":"Park KS, Seo YB, Lee JY, Im SJ, Seo SH, Song MS, Choi YK, Sung YC. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e. Vaccine. 2011;29:5481\u20137.","journal-title":"Vaccine"},{"key":"2889_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2020.114961","volume":"394","author":"BJ Ridder","year":"2020","unstructured":"Ridder BJ, Leishman DJ, Bridgland-Taylor M, Samieegohar M, Han X, Wu WW, Randolph A, Tran P, Sheng J, Danker T, Lindqvist A, Konrad D, Hebeisen S, Polonchuk L, Gissinger E, Renganathan M, Koci B, Wei H, Fan J, Levesque P, Kwagh J, Imredy J, Zhai J, Rogers M, Humphries E, Kirby R, Stoelzle-Feix S, Brinkwirth N, Rotordam MG, Becker N, Friis S, Rapedius M, Goetze TA, Strassmaier T, Okeyo G, Kramer J, Kuryshev Y, Wu Caiyun, Himmel H, Mirams GR, Strauss DG, Bardenet R, Li Z. A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigm. Toxicol Appl Pharmacol. 2020;394: 114961.","journal-title":"Toxicol Appl Pharmacol"},{"key":"2889_CR38","doi-asserted-by":"publisher","first-page":"24182","DOI":"10.1038\/srep24182","volume":"6","author":"P Saxena","year":"2016","unstructured":"Saxena P, Zangerl-Plessl EM, Linder T, Windisch A, Hohaus A, Timin E, Hering S, Stary-Weinzinger A. New potential binding determinant for hERG channel inhibitors. Sci Rep. 2016;6:24182.","journal-title":"Sci Rep"},{"key":"2889_CR39","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.jacep.2020.05.037","volume":"6","author":"T Shugg","year":"2020","unstructured":"Shugg T, Somberg JC, Molnar J, Overholser BR. \u2019Inhibition of human ether-A-go-go-related gene (hERG) potassium current by the novel Sotalol analogue Soestalol. JACC Clin Electrophysiol. 2020;6:756\u20139.","journal-title":"JACC Clin Electrophysiol"},{"key":"2889_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2023.105591","volume":"213","author":"S Son","year":"2023","unstructured":"Son S, Ahn SB, Kim G, Jang Y, Ko C, Kim M, Kim SJ. Identification of broad-spectrum neutralizing antibodies against influenza A virus and evaluation of their prophylactic efficacy in mice. Antiviral Res. 2023;213: 105591.","journal-title":"Antiviral Res"},{"key":"2889_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115653","volume":"298","author":"J Song","year":"2022","unstructured":"Song J, Zhao J, Cai X, Qin S, Chen Z, Huang X, Li R, Wang Y, Wang X. Lianhuaqingwen capsule inhibits non-lethal doses of influenza virus-induced secondary Staphylococcus aureus infection in mice. J Ethnopharmacol. 2022;298: 115653.","journal-title":"J Ethnopharmacol"},{"key":"2889_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121664","volume":"287","author":"Y Song","year":"2022","unstructured":"Song Y, Zhu W, Wang Ye, Deng L, Ma Y, Dong C, Gonzalez GX, Kim J, Wei L, Kang S-M, Wang B-Z. Layered protein nanoparticles containing influenza B HA stalk induced sustained cross-protection against viruses spanning both viral lineages. Biomaterials. 2022;287: 121664.","journal-title":"Biomaterials"},{"key":"2889_CR43","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jiac.2021.11.014","volume":"28","author":"H-C Su","year":"2022","unstructured":"Su H-C, Jung Feng I, Tang H-J, Shih M-F, Hua Y-M. Comparative effectiveness of neuraminidase inhibitors in patients with influenza: a systematic review and network meta-analysis. J Infect Chemother. 2022;28:158\u201369.","journal-title":"J Infect Chemother"},{"key":"2889_CR44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.celrep.2017.03.054","volume":"19","author":"N Tzarum","year":"2017","unstructured":"Tzarum N, de Vries RP, Peng W, Thompson AJ, Bouwman KM, McBride R, Yu Wenli, Zhu X, Verheije MH, Paulson JC, Wilson IA. The 150-loop restricts the host specificity of human H10N8 influenza virus. Cell Rep. 2017;19:235\u201345.","journal-title":"Cell Rep"},{"key":"2889_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2021.150380","volume":"805","author":"NV Ul\u2019yanovskii","year":"2022","unstructured":"Ul\u2019yanovskii NV, Kosyakov DS, Sypalov SA, Varsegov IS, Shavrina IS, Lebedev AT. Antiviral drug umifenovir (Arbidol) in municipal wastewater during the COVID-19 pandemic: estimated levels and transformation. Sci Total Environ. 2022;805: 150380.","journal-title":"Sci Total Environ"},{"key":"2889_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.106464","volume":"153","author":"T Wang","year":"2023","unstructured":"Wang T, Sun J, Zhao Qi. Investigating cardiotoxicity related with hERG channel blockers using molecular fingerprints and graph attention mechanism. Comput Biol Med. 2023;153: 106464.","journal-title":"Comput Biol Med"},{"key":"2889_CR47","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cell.2017.03.048","volume":"169","author":"W Wang","year":"2017","unstructured":"Wang W, MacKinnon R. Cryo-EM Structure of the Open Human Ether-\u00e0-go-go-Related K+ Channel hERG. Cell. 2017;169:422-30.e10.","journal-title":"Cell"},{"key":"2889_CR48","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.biopha.2017.04.091","volume":"91","author":"Y Wang","year":"2017","unstructured":"Wang Y, Ding Y, Yang C, Li R, Du Qiuling, Hao Y, Li Z, Jiang H, Zhao J, Chen Q, Yang Z, He Z. Inhibition of the infectivity and inflammatory response of influenza virus by Arbidol hydrochloride in vitro and in vivo (mice and ferret). Biomed Pharmacother. 2017;91:393\u2013401.","journal-title":"Biomed Pharmacother"},{"key":"2889_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2022.111292","volume":"555","author":"C Wilasang","year":"2022","unstructured":"Wilasang C, Suttirat P, Chadsuthi S, Wiratsudakul A, Modchang C. Competitive evolution of H1N1 and H3N2 influenza viruses in the United States: a mathematical modeling study. J Theor Biol. 2022;555: 111292.","journal-title":"J Theor Biol"},{"key":"2889_CR50","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1016\/j.bmcl.2017.06.074","volume":"27","author":"ZVF Wright","year":"2017","unstructured":"Wright ZVF, Wu NC, Kadam RU, Wilson IA, Wolan DW. Structure-based optimization and synthesis of antiviral drug Arbidol analogues with significantly improved affinity to influenza hemagglutinin. Bioorg Med Chem Lett. 2017;27:3744\u20138.","journal-title":"Bioorg Med Chem Lett"},{"key":"2889_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2023.121345","volume":"375","author":"M Yazdani","year":"2023","unstructured":"Yazdani M, Jafari A, Mahdian S, Namazi M, Gharaghani S. Rational approaches to discover SARS-CoV-2\/ACE2 interaction inhibitors: pharmacophore-based virtual screening, molecular docking, molecular dynamics and binding free energy studies. J Mol Liq. 2023;375: 121345.","journal-title":"J Mol Liq"},{"key":"2889_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100718","volume":"3","author":"A Zhang","year":"2022","unstructured":"Zhang A, Chaudhari H, Agung Y, D\u2019Agostino MR, Ang JC, Tugg Y, Miller MS. Hemagglutinin stalk-binding antibodies enhance effectiveness of neuraminidase inhibitors against influenza via Fc-dependent effector functions. Cell Reports Medicine. 2022;3: 100718.","journal-title":"Cell Reports Medicine"},{"key":"2889_CR53","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.1016\/j.vaccine.2022.09.058","volume":"40","author":"H Zhu","year":"2022","unstructured":"Zhu H, Li X, Ren X, Chen H, Qian P. Improving cross-protection against influenza virus in mice using a nanoparticle vaccine of mini-HA. Vaccine. 2022;40:6352\u201361.","journal-title":"Vaccine"},{"key":"2889_CR54","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jinf.2020.03.060","volume":"81","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Lu Zhaohui, Xu Tianmin, Chen C, Yang G, Zha T, Lu Jianchun, Xue Y. Arbidol monotherapy is superior to lopinavir\/ritonavir in treating COVID-19. J Infect. 2020;81:e21-3.","journal-title":"J Infect"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02889-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02889-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02889-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:51:47Z","timestamp":1757443907000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02889-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2889"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02889-2","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors confirm that the work described has not been published before. The publication has been approved by all authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"290"}}